Skip to main content
. Author manuscript; available in PMC: 2016 Nov 9.
Published in final edited form as: Expert Rev Pharmacoecon Outcomes Res. 2016 Oct 6;16(5):579–589. doi: 10.1080/14737167.2016.1239533

Table 1.

Characteristics of studies examining the economic burden of chronic conditions among cancer survivors.

Study Data sources Cancer survivor
population
Geographic
setting
Cancer patient
identification
Time frame of
costs
Cost by service type Individual
conditions
examined
Multiple chronic
conditions
Bernard et al. [24] 2001–2008 MEPS, and 2001–2008 NHIS-MEPS linked sample 4243 adults aged 18–64 years reporting any cancer diagnosis/receiving cancer treatment National Self-report 1 year Yes (0, 1+)
Boltz et al. [25] 1995–2005 SEER Medicare 2823 adults aged ≥65 years with a differentiated thyroid cancer diagnosis National Registry 1 and 5-year costs following diagnosis Yes (0, 1 or 2, 3+)
Cohen et al. 2003 [26] 1997 MEPS Adults aged ≥18 years with medical expenditures for any cancer. Sample size not provided. National Self-report 1 year Inpatient, ambulatory, prescription drugs, home health care Yes (1, 2, 3)
Davidoff et al. [27] 1997–2007 MCBS linked to Medicare claims 1868 Medicare beneficiaries aged >65 years with any cancer diagnosis National Claims 2 year following identification Yes (0–1, 2–4, 5–8, ≥9)
Forde et al. [28] 1992–2009 SEER Medicare 4506 women aged ≥65 years with an ovarian cancer diagnosis who underwent PDS or NACT National Registry/Claims 7-months after PDS or NACT Yes (0, 1, 2+)
Han et al. [29] 2008–2010 MEPS 4326 adults aged ≥18 years with any cancer ever diagnosed National Self-report 1 year Serious psychological distress
Hollenbeak et al. [32] 1984–1994 SEER Medicare 1780 Medicare beneficiaries with head and neck cancer diagnosisa National Registry 1 and 5-year costs Yes (WUHNCCI)
Hollenbeak et al. [31] 1995–2002 SEER Medicare 4938 Medicare beneficiaries with renal cell carcinoma ever diagnoseda National Registry 1 and 5-year costs following diagnosis Anemia, hyperlidemia Yes (CCI)
Hollenbeak et al. [30] 1995–2005 SEER Medicare 10711 Medicare beneficiaries aged ≥66 years with oral cavity (n = 6724) or pharyngeal cancer (n = 3987) ever diagnosed National Registry 5-year costs following diagnosis Yes (0, 1–2, 3+)
Luo et al. [33] 1996–2000 Michigan Medicaid and Medicare data merged with the Michigan Tumor Registry 6462 Medicare beneficiaries aged ≥66 years (765 were also insured by Medicaid) with colon cancer diagnosis Single state (Michigan) Registry 1 year following diagnosis Yes (0, 1, 2, 3+)
Pan et al. [34] 2006–2009 MEPS 4766 adults aged ≥21 years with any cancer National Self-report 1 year costs Inpatient, outpatient, prescription drugs, emergency department, otherb Depression
Subramanian et al. [21] 2000–2003 Medicaid administrative data linked to cancer registry data 6212 Medicaid beneficiaries aged 21–64 years with any cancer diagnosis Multiple states (Georgia, Maine, and Illinois) Registry 0–6 months following diagnosis Hospital stays, ambulatory care services, prescription drugs, long-term care Cardiac, Respiratory, Diabetes, Mental Health Yes (1, 2, 3–4)

MEPS: Medical Expenditure Panel Survey; NHIS: National Health Interview Survey; SEER: surveillance, epidemiology, end result; CCI: Charlson Comorbidity Index; WUHNCCI: Washington University Head and Neck Cancer Comorbidity Index; PDS: primary debulking surgery; NACT: neo-adjuvant chemotherapy; MCBS: Medicare Current Beneficiary Survey.

a

The age of Medicare beneficiaries included could not be ascertained from the published article; we assume aged ≥66 years.

b

Other expenditures include home health care, dental, vision, durable medical equipment, and other miscellaneous items.